Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS.

International audience

Data and Resources

Additional Info

Field Value
Source ISSN: 0923-7534
Author Houot, Roch, Le Gouill, Steven, Ojeda Uribe, Mario, Mounier, C., Courby, Stéphane, Dartigeas, Caroline, Bouabdallah, K., Alexis Vigier, M., Moles, Marie Pierre, Tournilhac, Olivier, Arakelyan, Nina, Rodon, Philippe, El Yamani, Abderrazak, Sutton, L., Fornecker, L., Assouline, D., Harousseau, Jean-Luc, Maisonneuve, Hervé, Caulet-Maugendre, Sylvie, Gressin, Rémi
Maintainer CCSD
Last Updated October 30, 2026, 15:40 (UTC)
Created October 30, 2026, 15:40 (UTC)
Identifier hal-00744066
Language en
contributor Microenvironnement et cancer (MiCa) ; Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes (Biosit : Biologie - Santé - Innovation Technologique)
creator Houot, Roch
date 2012-06-30T00:00:00
harvest_object_id c61e9314-451d-4cbb-b5f9-21aed293a923
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2026-10-14T00:00:00
relation info:eu-repo/semantics/altIdentifier/doi/10.1093/annonc/mdr450
set_spec type:ART